If there is any information that you would like included on this page please contact Alexandra Fullem (alexfullem@gmail.com). The website is updated approximately twice a month.
PDP Press Releases/ statements
• 1 Dec: IAVI Statement on World AIDS Day
• 4 Dec: Fierce optimism despite challenging circumstances
• 3 Dec: Quantifying 25 years of malaria control impact in Africa
• 9 Dec: Strengthening malaria control through better ITN surveillance
• 13 Nov: WHO Report Shows TB Gains, But Funding Gaps Threaten Momentum
• 19 Nov: Phase 2 Clinical Trial Results Show Potential to Shorten TB Treatment Time
• 12 Dec: Staying the course in 2025
• 14 Nov: Expanding access to malaria vaccines in Africa
• 2 Dec: First procurement of a preventive antimalarial from Swipha, a Nigerian manufacturer
• 4 Dec: WHO launches the 2025 World Malaria Report as pressure from drug resistance grows
• 13 Nov: Belém Health Action Plan (BHAP): Joint statement by CEPI, DNDi, MMV, and Unitaid
• 19 Nov: WHO approves first child-friendly primaquine formulations for malaria treatment
• 24 Nov: A race against time: antimalarial drug resistance
• 4 Dec: Dr Javid Abdelmoneim, Datuk Dr Mahathar bin Abd Wahab, Dr Taruna Madan, Violet Naanyu, and Dr Mario Santos Moreira join the Board of Directors at DNDi
• 8 Dec: DNDi statement on COP30: Advancing health in the climate agenda
• 3 Dec: IVI and the Regionalized Vaccine Manufacturing Collaborative sign partnership agreement to advance regional vaccine manufacturing and equity
• 9 Dec: Scientists in Korea to create mRNA vaccine against emerging tick-borne virus in Asia
• 8 Dec: Placental Malaria remains a major threat to mothers and newborns, new EVI study shows
• 10 Dec: Proving the value of malaria vaccines: how case-control studies can guide immunisation strategies
MDGH
PDP Funder News/Announcements
• 1 Dec: Lenacapavir use kicks off in South Africa and Brazil through Unitaid partnership with Wits RHI and Fiocruz. Unitaid
• 3 Dec: With Child Deaths Projected to Rise for the First Time This Century, Gates Foundation Urges Global Leaders to Target Scarce Resources Where They Save the Most Lives. Gates Foundation
• 3 Dec: €147 million available to fund global health research and innovation. EDCTP3
• 4 Dec: A transformative era for global health: Reflections on my journey with Unitaid. Unitaid
• 8 Dec: With Child Deaths Projected to Rise for the First Time in a Century, Gates Foundation and Mohamed Bin Zayed Foundation for Humanity Urge Action as World Faces Critical Turning Point. Gates Foundation
Funder Announcement Archives
• 2014 PDP Funder Announcements
• 2013 PDP Funder Announcements
New PDP Publications
• 25 Apr: Rethinking antibodies for infectious diseases?. IAVI
Other Reports/ Publications
• 4 Nov: More From Less: Optimising Vaccines in a Constrained World. CGD
• 10 Nov: Report: State of disunion: The impact of US funding cuts on global health R&D. Impact for Global Health
• 10 Nov: Pipeline Report: 2025 Tuberculosis Diagnostics. TAG
• 18 Nov: Genetically modified mosquitoes: Technology and access landscape report. Unitaid
• 25 Nov: The 2025 HIV Market Report: The state of the HIV market in low- and middle-income countries. CHAI
• 25 Nov: The changing impact of malaria control in Africa 2000-2025. Malaria Atlas Project
Related Press Releases/ Announcements/Articles
• 1 Dec: The end of malaria. Vox
• 1 Dec: Money Matters: New data on the world’s biggest development philanthropies. Devex
• 1 Dec: Africa is Stuck Between Global Pathogen-Sharing Talks and Conflicting US Bilateral Agreements. Health Policy Watch
• 1 Dec: Progress In Fight Against Malaria, As New Treatment Shows Promise. Forbes
• 1 Dec: 10 groundbreaking advances that grew out of HIV research. Duke University
• 1 Dec: New prevention tools and investment in services essential in the fight against AIDS. WHO
• 1 Dec: How vaccines – and yoghurt – could reduce colonisation with antibiotic-resistant bugs. Gavi
• 1 Dec: Medicines for All Institute develops low-cost process to make HIV-prevention medication. VCU News
• 1 Dec: Spillover in dengue trials. The Lancet Infectious Diseases
• 1 Dec: Spillover in dengue trials – Author's reply. The Lancet Infectious Diseases
• 1 Dec: SA wants to make its own six-monthly HIV prevention jabs by 2027. But there’s a hitch. Bhekisisa
• 1 Dec: Aid cuts have shaken HIV/Aids care to its core – and will mean millions more infections ahead. The Guardian
• 1 Dec: Treatment and prevention of HIV/AIDS: Unfinished business. PLOS Medicine
• 1 Dec: Lenacapavir Can Transform HIV Prevention—If Countries Support Access. Think Global Health
• 1 Dec: Efficacy and safety of a mosaic HIV-1 vaccine regimen in men who have sex with men and transgender individuals (HVTN 706/HPX3002/Mosaico): a global, randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet HIV
• 2 Dec: Global HIV prevention is not on track: how a health systems approach can promote sustainable progress in African countries. The Lancet HIV
• 2 Dec: Strengthening nationally led approaches to new product introduction for HIV prevention. The Lancet HIV
• 2 Dec: Aligning drug prices and innovation: How global spillovers shape the future of medicines. Vox EU
• 2 Dec: Snare of Bilateral Deals Hangs Over The Multilateral Effort On The Pathogen Access & Benefit Sharing System. Geneva Health Files
• 2 Dec: ‘Creeping catastrophe’: Climate change is driving global rise in infectious diseases, leading health experts warn. Centre for Tropical Medicine and Global Health
• 2 Dec: SA’s first batch of LEN jabs will arrive in February. Use our dashboard to find out who should get them. Bhekisisa
• 3 Dec: Uptake of dapivirine vaginal ring and oral pre-exposure prophylaxis among women accessing HIV prevention services in South Africa: a cohort study. The Lancet HIV
• 3 Dec: Congo hosts Africa’s first simulation exercise on antimicrobial resistance surveillance. WHO AFRO
• 3 Dec: Africa sets course for affordable, quality medicines with new 10-year roadmap. WHO AFRO
• 4 Dec: Global Malaria Threat Deepens as Drug Resistance Rises. Health Policy Watch
• 4 Dec: New tools saved a million lives from malaria last year but progress under threat as drug resistance rises. WHO
• 4 Dec: 200,000 children under the age of 5 to die this year because of foreign aid cuts. The Independent
• 4 Dec: Source of Lenacapavir for PrEP Supply to Early Adopter Countries. AVAC
• 4 Dec: Battle against malaria has stalled, WHO warns. The Telegraph
• 4 Dec: Reimagining global health architecture: the way forward to ensure global health security. The Lancet
• 4 Dec: Health data science revolution in Africa: potential for addressing the myriad health challenges. Nature
• 4 Dec: Zambia rolls out the malaria vaccine – and not a moment too soon. Gavi
• 4 Dec: Beyond Thimerosal: Preserving Vaccine Access Amid Growing Hesitation. Think Global Health
• 4 Dec: A new era dawns for Gavi, as Board underlines strategic shift towards country ownership and increased support for the most vulnerable. Gavi
• 4 Dec: Single-dose dengue vaccine ‘will help Amazon communities’. Gavi
• 4 Dec: Long-acting HIV treatment could improve outcomes for breastfeeding women. News Medical
• 4 Dec: FDA to lower number of trials required for approval of drugs, other medical products. STAT
• 4 Dec: Korea steps up pandemic response with $18.9m investment in CEPI. CEPI
• 4 Dec: US Signs pact with Kenya under America First global health plan. Reuters
• 4 Dec: Pathogens, Power and the Price of Aid: Why Africa Must Stand United. Global Policy Journal
• 4 Dec: Infection Prevention and Control Falters Post-Pandemic – Increasing AMR Risks. Health Policy Watch
• 4 Dec: Foreign aid cuts will see extra 200,000 children under five die this year, damning Gates report warns. The Independent
• 5 Dec: Collaboration Across Africa is Key to Increasing Clinical Trials. Health Policy Watch
• 5 Dec: 7 things you need to know about the state of malaria today. Gavi
• 5 Dec: In Kenya, smaller vaccine vials may mean more children protected. Gavi
• 5 Dec: Gavi Cuts Staff and Support to WHO and UNICEF – Gives More Freedom to Countries to Decide Vaccine Priorities. Health Policy Watch
• 5 Dec: Sabin Vaccine Institute’s Investigational Marburg Vaccine Delivered to Ethiopia for Outbreak Response. BioSpace
• 5 Dec: Countries to reconvene sooner to accelerate progress on WHO Pathogen Access and Benefit Sharing system negotiations. WHO
• 6 Nov: IAVI’s Lassa fever vaccine shows promise in early clinical trials. CEPI
• 6 Dec: US signs $228 mln deal with Rwanda for health under new aid model. Retuers
• 6 Dec: Gavi and World Bank Launch US$2B Partnership to Boost Immunization and Health Systems. Devidiscourse
• 7 Nov: B cells targeting parasites capture spatially linked antigens to secure T cell help. Science
• 7 Nov: American Barter: Aid In Exchange for Information on Pathogen. Geneva Health Files
• 7 Nov: "Relief" for mothers in Bayelsa state as malaria vaccine makes waves. Gavi
• 7 Nov: ‘Africa could be at a turning point in the fight against malaria’. Channel Africa
• 7 Nov: New study evaluates accuracy of rapid diagnostic tests for malaria. Centre for Tropical Medicine & Global Health
• 8 Dec: Global Health Innovative Technology Fund invests ¥70M in molecular mpox test. 360Dx
• 8 Dec: Scientists in Korea to create mRNA vaccine against emerging Asian tick-borne virus. CEPI
• 8 Dec: Kenya limits US access to disease outbreak data in new bilateral deal. Devex
• 8 Dec: Chikungunya adolescent vaccination and the distinct risk–benefit landscapes. The Lancet Infectious Diseases
• 8 Dec: Transitioning to people-centred antimicrobial resistance surveillance. The Lancet Infectious Diseases
• 8 Dec: Safety and immunogenicity of a live-attenuated chikungunya virus vaccine in adolescents: final results from a 12-month, double-blind, randomised, placebo-controlled, phase 3 trial in endemic areas of Brazil. The Lancet Infectious Diseases
• 8 Dec: US-Africa Bilateral Deals Steam Ahead as WHO Struggles to Finalise Global Pathogen Agreement. Health Policy Watch
• 8 Dec: First volunteer receives Lassa Fever vaccine in cutting-edge Oxford trial. University of Oxford
• 8 Dec: Developing Countries Push for Contractual Obligations for Pathogen Access & Benefit Sharing, As Africa-America Realpolitik Gathers Steam With Bilateral Deals. Geneva Health Files
• 9 Dec: On-Demand Dosing of HIV Preexposure Prophylaxis for Women: Has Their Time Finally Come?. The Journal of Infectious Diseases
• 9 Dec: 3 ways AI can support drug innovation and global research equity. Devex
• 9 Dec: How the Foundation is driving real progress toward global health equity. Access to Medicines Foundation
• 9 Dec: University of Oxford launches world’s first Phase II Nipah virus vaccine trial. CEPI
• 9 Dec: The 2024–2025 upsurge of mpox in Africa: another opportunity to accelerate global solidarity for a neglected disease. BMJ
• 9 Dec: Global Consortium Launched to Develop Next-Generation Malaria Vaccine. KEMRI-Wellcome
• 10 Dec: Imperial-led project brings gene-drive mosquitoes closer to reality in Africa. Imperial College London
• 10 Dec: Vaccines fall short in the countries that need them most: HypoVax Global aims to close the gap. LUMC
• 10 Dec: Top funders for malaria-related research and development globally. The Star
• 10 Dec: Mosquitoes outsmarting sprays, WHO report shows. Daily Nation
• 10 Dec: The fight to beat neglected tropical diseases was going well. 2025 could change that. NPR
• 10 Dec: Genetically engineered mosquitoes block development of circulating malaria strains. Nature
• 10 Dec: WHO and the European Commission expand partnership to combat antimicrobial resistance. WHO
• 10 Dec: Major milestone in development of Nipah virus vaccine. The Telegraph
• 10 Dec: FDA approves US-manufactured antibiotic under new priority review program. CIDRAP
• 10 Dec: Sinergium paves the way for Latin American mRNA vaccines with new preclinical study. CEPI
• 10 Dec: UNAIDS calls on African leaders to resource the HIV response, protect human rights, and seize the opportunity of new innovations to end AIDS. UNAIDS
• 11 Dec: Track the Science; Advance the Priorities: The 2025 Update of the People’s Research Agenda. AVAC
• 11 Dec: When politics Trumps science: Why the US isn’t giving SA LEN. Bhekisisa
• 11 Dec: Molecular epidemiology of Plasmodium falciparum drug resistance and vaccine targets in high-transmission settings in Africa. Nature
• 11 Dec: From promise to programs—How to ensure PrEP science is translated into global impact. Positively Aware
• 11 Dec: Zoliflodacin shows benefit as an oral treatment for uncomplicated gonorrhoea. The Lancet
• 11 Dec: New antibiotic can effectively treat gonorrhea, study finds. STAT
• 11 Dec: Global tuberculosis response off track: urgent priorities to end the world's top infectious killer. The Lancet
• 11 Dec: Prevention Intention: Wafaa El-Sadr on People and Persistence in HIV Research. CSIS
• 11 Dec: Africa CDC and Zipline Partner to Advance Health System Responsiveness and Epidemic Preparedness Across Africa. Africa CDC
• 11 Dec: Global Leaders Announce Independent Coalition to Reimagine the Future of Development Cooperation. Future of Development Cooperation
• 11 Dec: Scientists dream of beating malaria by editing disease-carrying mosquitoes' DNA. Could it work?. EuroNews
• 12 Dec: American Science, Shattered. STAT
• 12 Dec: The innovation development and access pathway: A holistic approach to accelerating access to innovative medicines and vaccines. IFPMA
• 12 Dec: FDA approves first new kind of drug to target gonorrhea in decades. STAT
• 12 Dec: The pain after the bite: Tracking Chikungunya’s debilitating impact in East Africa. CEPI
• 12 Dec: New CARB-X awards focus on novel diagnostics for respiratory infections. CIDkRAP
• 12 Nov: Scientific advances collide with major infrastructure upheaval. AVAC
• 12 Nov: Global gains in tuberculosis response endangered by funding challenges. WHO
• 12 Nov: WHO cites progress against TB globally but warns about reduced funding. CIDRAP
• 12 Nov: South Africa making first new cholera vaccine in decades. The Telegraph
• 13 Nov: New malaria treatment could fight growing threat of drug resistance. EuroNews
• 13 Nov: US has begun bilateral health negotiations with 16 African nations. Devex
• 13 Nov: Prequalifying the Qualified: The Lenacapavir Paradox. IHP
• 13 Nov: AMR is not just a medical crisis: It an ecological and governance crisis. IHP
• 13 Nov: Rift Valley fever vaccine safe, immune-producing in adults, early-stage trial shows. CIDRAP
• 13 Nov: Gilead hails phase 3 victory for single-tablet combo of bictegravir and lenacapavir, preps filings. Fierce Pharma
• 13 Nov: Weathering the Donor Downturn: The Case for a New Financial Model for the Global Fund. CGD
• 13 Nov: COP30 report reveals how climate change is spreading infectious diseases to new regions. The Conversation
• 13 Nov: AI to tailor malaria and TB drugs to Africa; fungus that lures mosquitoes; and how to address nutrition deficits on the continent. Nature
• 14 Nov: Safety outcomes among infants whose mothers used the dapivirine vaginal ring or oral PrEP during pregnancy (MTN-042/DELIVER): a randomised phase 3b study. The Lancet HIV
• 14 Nov: Single-dose malaria treatment as effective as multi-dose regimen, trial shows. CIDRAP
• 14 Nov: Denmark to cut IAVI funds, prioritizing multilaterals over smaller grants. Devex
• 15 Dec: A year in review: The global health innovation stories that shaped 2025. GHTC
• 15 Dec: Ethiopia’s first R21 malaria vaccine rollout, a global first in a refugee camp. MSF
• 15 Dec: Attivare Therapeutics Awarded $6.6 Million Grant to Advance Durable Malaria Vaccine. BioSpace
• 15 Dec: From Forest to Factory: Tracing the Supply Chains for Two Modern Adjuvants of Global Health Importance — QS-21 and MPL. TAG
• 15 Nov: Value profile for Malaria vaccines and monoclonal antibodies. Science
• 17 Nov: Many poor countries where experimental drugs are tested fail to benefit after approval, analysis finds. STAT
• 17 Nov: World AMR Awareness Week 2025 urges action to turn political commitments into life-saving interventions. WHO
• 17 Nov: African Diplomats Reaffirm Africa’s Unwavering Commitment to Global Health and Support to the Global Fund’s Replenishment. The Global Fund
• 17 Nov: Lenacapavir Plus Broadly Neutralizing Antibodies Maintains Viral Suppression. POZ
• 17 Nov: Malaria: Organic larvicide may achieve breakthrough. Daily Monitor
• 17 Nov: Trump slashed spending on clinical trials. The toll is starting to become clear. The Washington Post
• 17 Nov: Antibody responses to polymorphic Plasmodium falciparum merozoite antigens in Malawian children with severe and uncomplicated malaria. Malaria Journal
• 17 Nov: Exploring New Frontiers in the Fight Against Malaria. Health Policy Watch
• 17 Nov: Physical Accessibility of Medicines in Countries Hosting Trials for FDA Approvals. JAMA
• 18 Nov: First doses of HIV prevention drug lenacapavir delivered to Zambia, Eswatini. Reuters
• 18 Nov: New online hub for antimicrobial resistance data launches. CIDRAP
• 18 Nov: Staying the course amid change: Reflections on a season of global health engagement. GHTC
• 18 Nov: GSK and Fleming Initiative scientists unite to target AMR with advanced AI. GSK
• 18 Nov: Researchers call on UK to step up support for antimicrobial discovery and development. IDS
• 18 Nov: Awareness, acceptability, and willingness to pay for the R21/Matrix-M malaria vaccine: a cross-sectional study among pregnant women and nursing mothers in Enugu State, Nigeria. BMC Public Health
• 18 Nov: Recommendations to mitigate barriers to uptake and delivery of a four-dose malaria vaccine schedule: insights from the MVIP’s qualitative evidence. Malaria Journal
• 18 Nov: mRNA delivery of circumsporozoite protein epitope-based malaria vaccines induces protection in a mouse model. Nature
• 18 Nov: Innovation meets impact: Fighting malaria in a warming world. Devex
• 18 Nov: EXCLUSIVE: WHO Cutting Up to 25% of Staff by June 2026 – But ‘Shadow Workforce of Consultants’ Is Unreported. Health Policy Watch
• 18 Nov: The Malaria Vaccine Brings New Hope to Children and Caregivers in Zambia. Unicef
• 18 Nov: Trump administration touts moves to provide HIV prevention drug, but refuses to include South Africa. STAT
• 18 Nov: A 'breakthrough' drug to prevent HIV, an 'unprecedented' rollout. NPR
• 18 Nov: Trump Takes Credit for Lenacapavir Deal after His Administration Decimated U.S. International AIDS Prevention Programs. Public Citizen
• 18 Nov: US health strategy aims to position African governments as customers. Devex
• 18 Nov: How One Vaccine Could Help Fight Drug-Resistant Infections. Foreign Policy
• 19 Nov: Modelling the impact of different intervention packages for malaria control under varying intensities of pyrethroid resistance. Malaria Journal
• 19 Nov: Private Sector Mobilize Innovation for Health Equity and Resilience at B20 Global Health Breakout. The Global Fund
• 19 Nov: The Netherlands Reaffirms Commitment to Global Health. The Global Fund
• 19 Nov: More countries report rising levels of drug-resistant gonorrhoea, warns WHO. WHO
• 19 Nov: Global south's TB diagnostics innovations are key to fight the epidemic. Devex
• 19 Nov: As novel approaches drive TB testing expansion, global goal of disease eradication remains elusive. 360Dx
• 19 Nov: The future of global health is at stake. These 7 pioneers could revolutionize it. Vox
• 19 Nov: Researchers develop new method to combat antibiotic-resistant bacteria using bacteriophages. News Medical
• 19 Nov: New drug could be a breakthrough in treatment for killer TB, trial suggests. The Guardian
• 20 Nov: AI and citizens detect invasive mosquito in Madagascar. Gavi
• 20 Nov: Neglecting infectious diseases is a market failure. Financial Times
• 20 Nov: SA Calls for Unified African Action to Build Sustainable Vaccine Manufacturing. DeviDiscourse
• 20 Nov: Ethiopia battles first-ever Marburg outbreak. Gavi
• 20 Nov: A blueprint for access at the heart of outbreak R&D. CEPI
• 20 Nov: UK initiative to explore using AI to address antimicrobial resistance. CIDRAP
• 20 Nov: “We need to be intentional”: five voices on disability inclusive health research in Uganda. The London School of Tropical Medicine and Hygiene
• 20 Nov: South Africa is urged by advocates to issue a compulsory license for Gilead’s HIV prevention drug. STAT
• 20 Nov: Global Fund Seeks $14 Billion at Replenishment Summit – With Progress Against HIV, TB and Malaria at Risk. Health Policy Watch
• 20 Nov: Fundraising summit for Aids, TB and malaria expected to fall billions of pounds short. The Telegraph
• 21 Nov: Beyond the Breakthrough: The Uneven Geography of mRNA Vaccine Production. Geneva Health Files
• 21 Nov: Common bacterial infections becoming increasingly untreatable, WHO warns. Gavi
• 21 Nov: Global Fund raised $11.34 billion with a surprising US pledge. Devex
• 21 Nov: First look: Full Text of America First Global Health Strategy Specimen Sharing Agreement. Emily Bass
• 21 Nov: First Deliveries of Gilead's Twice-Yearly HIV Prevention Therapy in Sub-Saharan Africa – and What it Means for Ending the HIV Epidemic. Gilead
• 21 Nov: Evolving the global HIV/AIDS response: Emerging tools and new opportunities. GHTC
• 21 Nov: Exclusive: CDC to end all monkey research. Science
• 21 Nov: Africa CDC Launches AGARI, a Continent-Wide Genomic Data Platform to Strengthen Outbreak Response. Africa CDC
• 21 Nov: Africa CDC Unveils a New Vision for Health Security and Sovereignty Across the Continent. Africa CDC
• 22 Nov: The European Investment Bank's focus on health. The Lancet
• 22 Nov: Africa's Health Security and Sovereignty agenda: a new way forward. The Lancet
• 22 Nov: Control of HIV, TB and malaria at risk after global health fund donations fall. The Guardian
• 23 Nov: Malaria vaccine price cut set to protect 7 million more children by 2030. UN News
• 24 Nov: Gavi and UNICEF announce equitable pricing deal for malaria vaccine to protect 7 million more children by end of decade. Gavi
• 24 Nov: Investing in opportunity: How venture capital powers social impact. Devex
• 24 Nov: UNICEF, Gavi deal slashes malaria vaccine price to $2.99 per dose. Devex
• 24 Nov: Strengthening global preparedness and response to arboviral disease threats: a call to action. The Lancet
• 24 Nov: GSK and ISGlobal Sign Framework Agreement to Advance Global Health Research. IS Global
• 24 Nov: Fightback: scientists score series of wins in battle against superbugs. The Telegraph
• 24 Nov: Marburg outbreak worsens in Ethiopia as death toll rises. The Telegraph
• 24 Nov: HIV Prevention R&D at Risk. AVAC
• 24 Nov: To tackle rising antibiotic resistance, GARDP aims for access. CIDRAP
• 24 Nov: New vapor tool fights mosquitoes by slowly releasing insecticide in homes. Will it catch on?. Science
• 24 Nov: "The biggest tech transfer program in the history of all medical technology": Petro Terblanche, CEO, Afrigen Biologics And Vaccines on the mRNA Tech Transfer Programme . Geneva Health Files
• 25 Nov: EDCTP: Two decades of Africa-Europe partnership delivering excellent science and life-saving innovations. Science Business
• 25 Nov: New WHO framework aims to tackle rising resistance to HIV, STI, and hepatitis treatments. CIDRAP
• 25 Nov: Antibiotic resistance: how a pioneering trial is using old drugs to save babies from sepsis. The Guardian
• 25 Nov: Lawmakers probe FDA's new priority voucher program, cite corruption and rushed review concerns. Fierce Biotech
• 26 Nov: New vaccines could help us consign tuberculosis to history: here’s how we can do it. Gavi
• 26 Nov: Some high-flying tropical mosquitoes carry disease-causing pathogens long distances, study finds. CIDRAP
• 26 Nov: A Turning Point: Lusaka Agenda is Anchored in the G20 Declaration. Health Policy Watch
• 26 Nov: Can AI Democratize the Global Fight Against Malaria?. Health Policy Watch
• 26 Nov: A much-needed vaccine for Nipah virus. Nature
• 26 Nov: Brazil approves world's first single-dose dengue vaccine. France24
• 27 Nov: Breakthrough in Malaria Prevention: New Vaccine and Adjuvant Unveiled. Devidiscourse
• 27 Nov: “Miraculous” HIV drug to be rolled out after overcoming aid cuts threat. BMJ
• 27 Nov: Patronus Biotech receives grant to evaluate a novel malaria vaccine and adjuvant to support affordable access and use in global health. The Korea Herald
• 27 Nov: “Act Now!” Yes, but with what, exactly? On #AMR and the realities of unequal access. IHP
• 27 Nov: What will the Global Development Architecture look like in 2030? And What can the EU and UK do to Influence It?. Global Policy Journal
• 27 Nov: Beyond resistance: alternative innovation models for global access and stewardship of new antibiotics. Nature
• 28 Nov: Antiviral drug abandoned by pharma shows promise against dengue. Science
• 28 Nov: FDA seeks more oversight of vaccine trials and approvals. The New York Times
• 29 Nov: Amid massive cuts, Global Fund raises $11 billion. The Lancet
• 29 Nov: The Global Fund and the future of global health. The Lancet
• 29 Nov: The New U.S. Global Health Strategy — A Reset of America’s Health Cooperation. NEJM
Upcoming Meetings/ Webinars
--------------------------